Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL487339 | 0.75 | PIK3CD (0.43) | RECQLFYNACHE | |
| SCHEMBL25181915 | 0.71 | GCGR (0.34) | FYN | |
| SCHEMBL14421716 | 0.70 | — | — | |
| SCHEMBL10265983 | 0.68 | GPR35 (0.35) | — | |
| SCHEMBL4050058 | 0.67 | — | — | |
| SCHEMBL10487423 | 0.67 | — | — | |
| SCHEMBL11823349 | 0.67 | — | — | |
| SCHEMBL8892322 | 0.67 | — | — | |
| SCHEMBL1368428 | 0.67 | FYN (0.36) | RECQLFYN | |
| SCHEMBL9649790 | 0.67 | CPB2 (0.50) | RECQLFYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118373769-A | Compounds and methods for peptide purification | 格瑞罗斯普罗泰恩科技公司 | 2024-07-23 | — | — | CN | disclosed |
| CN-118373757-A | Compounds and methods for peptide purification | 格瑞罗斯普罗泰恩科技公司 | 2024-07-23 | — | — | CN | disclosed |
| CN-118373759-A | Compounds and methods for peptide purification | 格瑞罗斯普罗泰恩科技公司 | 2024-07-23 | — | — | CN | disclosed |
| CN-118373758-A | Compounds and methods for peptide purification | 格瑞罗斯普罗泰恩科技公司 | 2024-07-23 | — | — | CN | disclosed |
| CN-112638864-B | Traceless reductive cleavable linker molecules for peptide purification | 格瑞罗斯普罗泰恩科技公司 | 2024-03-08 | — | — | CN | disclosed |
| US-20210332082-A1 | TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES FOR PEPTIDE PURIFICATION | Belyntic GmbH (DE) | 2021-10-28 | — | — | US | disclosed |
| CN-112638864-A | Traceless reductively cleavable linker molecules for peptide purification | 贝兰迪克有限责任公司 | 2021-04-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210332082-A1 | TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES FOR PEPTIDE PURIFICATION | VIP, NGLY1, HM13 | RECQL 3343/4885FYN 3513/4885ACHE 2376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.